The state of District Of Columbia currently has 1 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Washington, Washington, D.C., Washington DC and Washington, Dc.
A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease
This is a multi-center, randomized, double blind, adaptive, parallel-group, placebo controlled Phase 1b study to evaluate the safety, tolerability, pharmacokinetic (PK) and pharmacodynamics of RO7486967 in participants with idiopathic PD at the early stage of the disease (modified H&Y stage ≤2.5) who are either treatment-naïve or on stable treatment with symptomatic therapy (levodopa and/or pramipexole, ropinirole, rotigotine).
Between 40 years and 85 years
Trial Updated:
Locations: Georgetown University, Washington, District of Columbia
Conditions: Parkinson Disease